NVPX
HCAT icon

Norwest Venture Partners XII’s Health Catalyst HCAT Stock Holding History

Norwest Venture Partners XII’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$32.1M Sell
876,045
-1,476,045
-63% -$50.1M 69.68% 1
2020
Q2 		$68.6M Hold
2,352,090
– – 79.76% 1
2020
Q1 		$61.5M Sell
2,352,090
-600,000
-20% -$18.3M 88.08% 1
2019
Q4 		$102M Buy
+2,952,090
New +$97.7M 100% 1

Other funds holding HCAT

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Norwest Venture Partners XII's HCAT Position: Q3 2020 in Review

Norwest Venture Partners XII reduced its Health Catalyst (HCAT) stake by 63% in Q3 2020, selling an estimated $50.1M and leaving 876,045 shares worth $32.1M. The position accounts for 69.68% of the portfolio, ranked #1.

Norwest Venture Partners XII first reported a position in HCAT in Q4 2019 and has held it in 4 quarters since. The position peaked at $102M in Q4 2019. 138 funds tracked by Wall St. Rank hold HCAT as of Q3 2020.

  • Norwest Venture Partners XII held 876,045 shares of Health Catalyst worth $32.1M as of Q3 2020.
  • Norwest Venture Partners XII sold 1,476,045 Health Catalyst shares in Q3 2020, an estimated $50.1M.
  • Health Catalyst made up 69.68% of Norwest Venture Partners XII's portfolio in Q3 2020, its #1 holding.
  • Norwest Venture Partners XII first reported a position in Health Catalyst in Q4 2019 and has held it in 4 quarters since.
  • Norwest Venture Partners XII's Health Catalyst position peaked at $102M in Q4 2019.
  • 138 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2020.

Based on Norwest Venture Partners XII's 13F filing for Q3 2020, filed 23 Oct 2020.